Related Experiment Videos
[Errors in patients with infections]
1Universitätsklinik, Kantonsspital Liestal. werner.zimmerli@unibas.ch
Abstract:
Problems in the management of patients with infections are illustrated with three cases. The first case underlines the need for knowledge about antibiotic resistance pattern and mechanisms, as well as about clinical treatment studies for the correct management of endocarditis. The second case shows that results of microbiological samples may provide irrelevant data on which the treatment with suboptimal or wrong antimicrobial agents is based. The third case illustrates that the analysis of an infection should be a continuous process. Each microbiological result should initiate reevaluation, in order to optimize treatment. Criteria for adapting therapy are the in-vitro susceptibility of the infecting agent, the risk of emergence of resistance during treatment, results of published clinical studies, as well as toxicity and price of the antibiotic. All three cases illustrate the impact of an infectious disease specialist who should not only provide clinical knowledge, but also information about microbiology and epidemiology.
Insights
Effective infection management requires understanding antibiotic resistance and continuous patient monitoring. Infectious disease specialists are crucial for optimizing antimicrobial therapy based on microbiology and epidemiology.
Area of Science:
- Infectious Diseases
- Clinical Microbiology
- Pharmacology
Background:
- Managing complex infections necessitates a deep understanding of antimicrobial resistance patterns and clinical evidence.
- Current treatment strategies may falter due to reliance on potentially irrelevant microbiological data.
- The dynamic nature of infections requires ongoing assessment and adaptation of therapeutic approaches.
Observation:
- Case studies highlight challenges in endocarditis management due to antibiotic resistance.
- Suboptimal antimicrobial treatment can arise from misinterpreting microbiological sample results.
- Infection analysis must be a continuous process, with each microbiological finding prompting reevaluation.
Findings:
- Optimizing antimicrobial therapy depends on in-vitro susceptibility, resistance emergence risk, clinical studies, and drug properties (toxicity, cost).
- Infectious disease specialists play a vital role, integrating clinical, microbiological, and epidemiological insights.
- Tailoring treatment based on evolving data is essential for successful patient outcomes.
Implications:
- Improved patient outcomes through evidence-based, adaptive antimicrobial strategies.
- Enhanced role of infectious disease specialists in multidisciplinary patient care.
- Need for continuous education on antibiotic resistance and treatment guidelines.
Related Concept Videos
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Urine Studies II: Urine Culture and Sensitivity Test
Urinary Tract Infection II: Pathophysiology
Endocarditis I: Introduction
Urinary Tract Infection I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management